Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries RayzeBio, Inc. - Common Stock (NQ: RYZB ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about RayzeBio, Inc. - Common Stock Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer February 23, 2024 From Bristol Myers Squibb Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Masonite International Corporation (NYSE – DOOR), ZeroFox Holdings, Inc. (Nasdaq – ZFOX), RayzeBio, Inc. (Nasdaq – RYZB) February 12, 2024 From Brodsky & Smith LLC Via GlobeNewswire Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period February 12, 2024 From Bristol Myers Squibb Via Business Wire Pancreatic Cancer Treatments Poised for Major Advances in 2024 February 07, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END Via FinancialNewsMedia IPO watch 2024: Which new stocks will hit the market? January 08, 2024 Expectations are high for the 2024 IPO market, with Reddit, Databricks, and Shein debuts anticipated, hinting at a substantial influx of new public companies. Via MarketBeat Topics Initial Public Offering Exposures Securities Market BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) January 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire RAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB December 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals December 29, 2023 Bristol Myers announced two acquisitions in a week. The pharma giant is boosting its neuroscience pipeline with Karuna and its oncology pipeline with RayzeBio. Via MarketBeat BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) December 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire RYZB Stock Alert: Halper Sadeh LLC Is Investigating RayzeBio, Inc. December 26, 2023 From Halper Sadeh LLC Via Business Wire Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio December 26, 2023 From Rayzebio, Inc. Via GlobeNewswire Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio December 26, 2023 From Bristol Myers Squibb Via Business Wire RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 13, 2023 From Rayzebio, Inc. Via GlobeNewswire RayzeBio to Participate in Upcoming Investor Conferences in November 2023 November 06, 2023 From Rayzebio, Inc. Via GlobeNewswire RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors November 01, 2023 From Rayzebio, Inc. Via GlobeNewswire FDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETs October 24, 2023 From Rayzebio, Inc. Via GlobeNewswire RayzeBio to Present at European Society for Medical Oncology (ESMO) Congress October 18, 2023 From Rayzebio, Inc. Via GlobeNewswire RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares September 19, 2023 From RayzeBio, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
